.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Medtronic
Queensland Health
McKinsey
Farmers Insurance
Teva
Baxter
Johnson and Johnson
Daiichi Sankyo

Generated: December 17, 2017

DrugPatentWatch Database Preview

PROVENTIL-HFA Drug Profile

« Back to Dashboard

When do Proventil-hfa patents expire, and when can generic versions of Proventil-hfa launch?

Proventil-hfa is a drug marketed by 3m Drug Delivery and is included in one NDA. There is one patent protecting this drug.

This drug has eighteen patent family members in ten countries.

The generic ingredient in PROVENTIL-HFA is albuterol sulfate. There are thirty-seven drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
Drug patent expirations by year for PROVENTIL-HFA

Pharmacology for PROVENTIL-HFA

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996BXRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROVENTIL-HFA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996► Subscribe► Subscribe
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996► Subscribe► Subscribe
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996► Subscribe► Subscribe
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996► Subscribe► Subscribe
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996► Subscribe► Subscribe
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996► Subscribe► Subscribe
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996► Subscribe► Subscribe
3m Drug DeliveryPROVENTIL-HFAalbuterol sulfateAEROSOL, METERED;INHALATION020503-001Aug 15, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: PROVENTIL-HFA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,290,539 Device for delivering an aerosol► Subscribe
6,030,682 Container for aerosol formulation► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PROVENTIL-HFA

Country Document Number Estimated Expiration
JapanH06504307► Subscribe
Mexico9102764► Subscribe
World Intellectual Property Organization (WIPO)9211190► Subscribe
South Africa9110143► Subscribe
Australia4576096► Subscribe
Denmark0673857► Subscribe
Australia5075596► Subscribe
European Patent Office0673857► Subscribe
Japan3260752► Subscribe
Canada2098727► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Medtronic
Fish and Richardson
US Army
Novartis
UBS
Accenture
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot